| Identification | Back Directory | [Name]
Trimethoprim Related Compound B (25 mg) (2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone) (AS) | [CAS]
30806-86-1 | [Synonyms]
Trimethoprim EP Impurity B
Trimethoprim Keto Analogue
Trimethoprim USP Related Compound B
(2,4-Diaminopyrimidin-5-yl)-(3,4,5-
Trimethoprim Impurity 2 (Trimethoprim EP Impurity B)
(2,4-Diamino-5-pyrimidinyl)(3,4,5-trimethoxyphenyl)methanone
Methanone,(2,4-diaMino-5-pyriMidinyl)(3,4,5-triMethoxyphenyl)-
Trimethoprim EP Impurity B (Trimethoprim USP Related Compound B)
Trimethoprim Related Compound B(Secondary Standards traceble to USP)
(2,4-Diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone (Trimethoprim Impurity)
Trimethoprim Related Compound B (2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone) (1692527)
Trimethoprim Related Compound B (25 mg) (2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone) (AS)
Trimethoprim EP Impurity B/Trimethoprim USP RC B/(2,4-Diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone | [Molecular Formula]
C14H16N4O4 | [MDL Number]
MFCD22666234 | [MOL File]
30806-86-1.mol | [Molecular Weight]
304.3 |
| Chemical Properties | Back Directory | [Melting point ]
152-154 °C(Solv: benzene (71-43-2)) | [Boiling point ]
616.4±65.0 °C(Predicted) | [density ]
1.319±0.06 g/cm3(Predicted) | [solubility ]
soluble in Methanol | [pka]
4.71±0.10(Predicted) | [Major Application]
pharmaceutical | [InChI]
1S/C14H16N4O4/c1-20-9-4-7(5-10(21-2)12(9)22-3)11(19)8-6-17-14(16)18-13(8)15/h4-6H,1-3H3,(H4,15,16,17,18) | [InChIKey]
GAAPPIKAFNZRLA-UHFFFAOYSA-N | [SMILES]
Nc1nc(c(cn1)C(=O)c2cc(c(c(c2)OC)OC)OC)N |
| Safety Data | Back Directory | [WGK Germany ]
WGK 3 | [HS Code ]
2933599550 | [Storage Class]
6.1D - Non-combustible acute toxic Cat.3
toxic hazardous materials or hazardous materials causing chronic effects | [Hazard Classifications]
Acute Tox. 3 Oral
Repr. 2 |
| Hazard Information | Back Directory | [Uses]
5-(3,4,5-Trimethoxybenzoyl)-2,4-pyrimidinediamine, is a derivative of Trimethoprim (T795615), an antibacterial agent. 5-(3,4,5-Trimethoxybenzoyl)-2,4-pyrimidinediamine, is a possible potent and selective inhibitor targeting dihydrofolate reductase of C. hominis, used for the treatment of Cryptosporidiosis. |
|
|